Projects per year
Fingerprint
Dive into the research topics where Asher A Chanan Khan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Therapeutic implication of CD38 in CLL
Chanan Khan, A. A. & Chini, E. N.
9/4/19 → 8/31/22
Project: Research project
-
VACCINE FOR PATIENTS WITH NON HODGKINS LYMPHOMA
Bernstein, S. & Chanan Khan, A. A.
9/18/00 → 9/1/03
Project: Research project
Research output
-
Awareness of myeloma care and the global impact of treatment: An international internet-based prospective study
Ailawadhi, S., Swaika, A., Advani, P., Hodge, D., Paulus, A., Khera, N., Hashmi, S. K., Alegria, V. R., Abdulazeez, M., Bodepudi, S., Jamwal, K., Roy, V., Sher, T., Chanan-Khan, A. & Ailawadhi, M., Mar 2022, In: Journal of Oncology Pharmacy Practice. 28, 2, p. 425-433 9 p.Research output: Contribution to journal › Article › peer-review
-
Dihydronicotinamide Riboside Is a Potent NAD+ Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages
Chini, C. C. S., Peclat, T. R., Gomez, L. S., Zeidler, J. D., Warner, G. M., Kashyap, S., Mazdeh, D. Z., Hayat, F., Migaud, M. E., Paulus, A., Chanan-Khan, A. A. & Chini, E. N., Feb 25 2022, In: Frontiers in immunology. 13, 840246.Research output: Contribution to journal › Article › peer-review
Open Access -
Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia
Parrondo, R. D., Paulus, A., Alegria, V., Liebowitz, D., Johnson, C., Clynes, R., Roy, V., Menke, D. M., Jiang, L., Chanan-Khan, A. A. & Ailawadhi, S., 2022, In: Leukemia and Lymphoma. 63, 3, p. 738-742 5 p.Research output: Contribution to journal › Letter › peer-review
-
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis
Parrondo, R. D., Sam, K., Rasheed, A., Alegria, V., Sher, T., Roy, V., Chanan-Khan, A. & Ailawadhi, S., Apr 2022, In: Blood cancer journal. 12, 4, 66.Research output: Contribution to journal › Letter › peer-review
Open Access -
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Byrd, J. C., Hillmen, P., Ghia, P., Kater, A. P., Chanan-Khan, A., Furman, R. R., O’Brien, S., Nuri Yenerel, M., Illés, A., Kay, N., Garcia-Marco, J. A., Mato, A., Pinilla-Ibarz, J., Seymour, J. F., Lepretre, S., Stilgenbauer, S., Robak, T., Rothbaum, W., Izumi, R., Hamdy, A. & 4 others, , Nov 1 2021, In: Journal of Clinical Oncology. 39, 31, p. 3441-3452 12 p.Research output: Contribution to journal › Article › peer-review
Open Access